Lactobacillus Constipation Meta-analysis: What the Evidence Says

Quick Answer

Lactobacillus Constipation Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 guideline.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Meta-analyses also demonstrated that Bacillus coagulans MTCC 5856 improved quality of life for those with IBS. [Maslennikov R (2026); evidence level 1]
• Background: Many probiotic strains have been studied in relation to irritable bowel syndrome (IBS). [Maslennikov R (2026); evidence level 1]
• This review summarizes the current concepts of probiotics and evaluates evidence supporting their use in patients with lower GI disorders, with a focus on potential sex-related differences. [Kim Yong Sung (2026); evidence level 2]
• Saccharomyces, Lactobacillus Bifidobacterium Clostridium difficile 7 This review was conducted to summarize and interpret the current evidence on probiotics on IBS, FC, and CDI in terms of sex differences. [Kim Yong Sung (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For lactobacillus constipation meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Maslennikov R (2026). Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.. DOI: 10.3390/jcm15031152. PMCID: PMC12898053. PMID: 41682832. https://pmc.ncbi.nlm.nih.gov/articles/PMC12898053/
• Kim Yong Sung (2026). Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences. DOI: 10.5056/jnm25221. PMCID: PMC13071424. PMID: 41807013. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0 This is an open-access .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13071424/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.